Literature DB >> 25215090

Association of ALOX5, LTA4H and LTC4S gene polymorphisms with ischemic stroke risk in a cohort of Chinese in east China.

Gan-Nan Wang1, Jin-Song Zhang1, Wei-Juan Cao1, Hao Sun1, Jing Zhang1, Yao Wang1, Hang Xiao2.   

Abstract

BACKGROUND: Genetic variations of the 5-lipoxygenase activating protein and leukotriene A4 hydrolase genes that confer an increased risk of ischemic stroke have implicated the family of leukotrienes as potential mediators of ischemic stroke. This study aimed to explore the association of ALOX5, LTA4H and LTC4S gene polymorphisms with ischemic stroke risk in a cohort of Chinese in east China.
METHODS: This case-control study consisted of 690 patients with ischemic stroke and 690 controls. Polymorphisms of ALOX5 rs2029253 A/G, LTA4H rs6538697 T/C, and LTC4S rs730012 A/C were genotyped by the polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) analysis. The multivariate logistic regression model was used to exclude the effects of conventional risk factors on ischemic stroke.
RESULTS: Carriers of C allele in rs730012 were more susceptible to ischemic stroke (OR: 1.37; 95%CI: 1.08-1.73; P=0.009). The rs2029253 GG genotype showed a risk-reducing effect on ischemic stroke (OR: 0.72; 95%CI: 0.55-0.93; P=0.013) while the rs6538697 CC genotype had an increased risk of ischemic stroke (OR: 1.77; 95%CI: 1.09-2.89; P=0.022). The rs730012 variant was not associated with ischemic stroke risk after adjusting confounding factors (P>0.05).
CONCLUSION: The present study suggested that gene polymorphisms in the leukotrienes pathway may exert influences, with independent genetic effects, on ischemic stroke susceptibility in a cohort of Chinese in east China.

Entities:  

Keywords:  Gene polymorphisms; Ischemic stroke; Leukotrienes; Risk factors

Year:  2013        PMID: 25215090      PMCID: PMC4129893          DOI: 10.5847/wjem.j.issn.1920-8642.2013.01.006

Source DB:  PubMed          Journal:  World J Emerg Med        ISSN: 1920-8642


  29 in total

Review 1.  Computational analysis of gene-gene interactions using multifactor dimensionality reduction.

Authors:  Jason H Moore
Journal:  Expert Rev Mol Diagn       Date:  2004-11       Impact factor: 5.225

Review 2.  The 5 lipoxygenase system in the vasculature: emerging role in health and disease.

Authors:  Etty Osher; Gary Weisinger; Rona Limor; Karen Tordjman; Naftali Stern
Journal:  Mol Cell Endocrinol       Date:  2006-05-02       Impact factor: 4.102

Review 3.  Leukotrienes.

Authors:  Marc Peters-Golden; William R Henderson
Journal:  N Engl J Med       Date:  2007-11-01       Impact factor: 91.245

Review 4.  Leukotrienes and atherosclerosis.

Authors:  Graziano Riccioni; Magnus Bäck; Valérie Capra
Journal:  Curr Drug Targets       Date:  2010-07       Impact factor: 3.465

Review 5.  Proinflammatory gene polymorphisms and ischemic stroke.

Authors:  Yoshiji Yamada; Sahoko Ichihara; Tamotsu Nishida
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

Review 6.  Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies.

Authors:  Roland Klingenberg; Göran K Hansson
Journal:  Eur Heart J       Date:  2009-10-30       Impact factor: 29.983

Review 7.  What's all the FLAP about?: 5-lipoxygenase-activating protein inhibitors for inflammatory diseases.

Authors:  Jilly F Evans; Andrew D Ferguson; Ralph T Mosley; John H Hutchinson
Journal:  Trends Pharmacol Sci       Date:  2008-01-09       Impact factor: 14.819

8.  Cigarette smoking and risk of stroke in the chinese adult population.

Authors:  Tanika N Kelly; Dongfeng Gu; Jing Chen; Jian-Feng Huang; Ji-Chun Chen; Xiufang Duan; Xigui Wu; Chung-Shiuan Chen; Jiang He
Journal:  Stroke       Date:  2008-03-06       Impact factor: 7.914

9.  Proportion of different subtypes of stroke in China.

Authors:  Lin-Feng Zhang; Jun Yang; Zhen Hong; Guang-Gu Yuan; Bei-Fan Zhou; Lian-Cheng Zhao; Yi-Ning Huang; Jie Chen; Yang-Feng Wu
Journal:  Stroke       Date:  2003-08-07       Impact factor: 7.914

10.  Candidate gene polymorphisms for ischemic stroke.

Authors:  Mar Matarin; W Mark Brown; Hernandez Dena; Angela Britton; Fabienne Wavrant De Vrieze; Thomas G Brott; Robert D Brown; Bradford B Worrall; L Douglas Case; Stephen J Chanock; E Jeffrey Metter; Luigi Ferruci; Dale Gamble; John A Hardy; Stephen S Rich; Andrew Singleton; James F Meschia
Journal:  Stroke       Date:  2009-09-03       Impact factor: 7.914

View more
  4 in total

Review 1.  Genetic and Epigenetic Components of Aspirin-Exacerbated Respiratory Disease.

Authors:  Amber Dahlin; Scott T Weiss
Journal:  Immunol Allergy Clin North Am       Date:  2016-11       Impact factor: 3.479

2.  Association analysis of APO gene polymorphisms with ischemic stroke risk: a case-control study in a Chinese Han population.

Authors:  Rongjun Xiao; Shuaiqi Sun; Jiayi Zhang; Yongri Ouyang; Ning Zhang; Min Yang; Tianbo Jin; Ying Xia
Journal:  Oncotarget       Date:  2017-02-20

Review 3.  Complementary Participation of Genetics and Epigenetics in Development of NSAID-exacerbated Respiratory Disease.

Authors:  Jong Uk Lee; Jong Sook Park; Hun Soo Chang; Choon Sik Park
Journal:  Allergy Asthma Immunol Res       Date:  2019-11       Impact factor: 5.764

4.  Gene Polymorphism of Aspirin-Induced Urticaria in Children With Kawasaki Disease.

Authors:  Hui Zhang; Lin Shi; Xiao Hui Li; Ming Ming Zhang; Yao Lin; Yang Liu; Aijie Li
Journal:  Front Pediatr       Date:  2019-12-06       Impact factor: 3.418

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.